APBI 2016

Less local treatment: where is the limit? Side effects

Continuation of tamoxifen treatment after adjuvant tamoxifen for 1–4 years may provide Japanese breast cancer patients with better HRQOL than by switching to anastrozole.

Ohsumi S, et al. Breast Cancer Res Treat. 2011;127:143–152